Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

An In Vivo Mouse Model for Testing the Effect On Hematopoietic Stem Cell Mobilization of Bortezomib Alone and in Combination with G-CSF.

Yair Gazitt, PhD, Xiangru Zhao, MS

Blood (2009) 114 (22): 2156.

https://doi.org/10.1182/blood.V114.22.2156.2156

Published: 2009

Journal Articles

Not all that glitters is gold

Yair Gazitt

Blood (2005) 106 (13): 4025–4026.

https://doi.org/10.1182/blood-2005-09-3835

Published: 2005

Journal Articles

Synergy between 17 AAG and Arsenic Trioxide in the Induction of Apoptosis in Myeloma Cell Lines.

Yair Gazitt, PhD, Cagla Akay, M.D, Fatih Kircelli, M.D.

Blood (2005) 106 (11): 5055.

https://doi.org/10.1182/blood.V106.11.5055.5055

Published: 2005

Journal Articles

Global Gene Expression Changes during Arsenic Trioxide -Induced Apoptosis in Myeloma Cell Lines Expressing Mutant or w.t p53.

Yair Gazitt, PhD, Cagla Akay, MD, Fatih Kircelli, MD

Blood (2005) 106 (11): 4351.

https://doi.org/10.1182/blood.V106.11.4351.4351

Published: 2005

Journal Articles

Arsenic Trioxide Induced p53-Dependant Apoptotic Signals in a Temperature Sensitive (Ts) p53 Mutant, BRK Cell Line.

Cagla Akay, M.D, Yair Gazitt, Ph.D

Blood (2004) 104 (11): 4318.

https://doi.org/10.1182/blood.V104.11.4318.4318

Published: 2004

Journal Articles

Synergy between CD52 and CD20 Antibody-Induced Apoptosis Correlates with the Extent of Co-Expression of CD20 and CD52 Antigens on Mononuclear Cells Derived from Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL) Patients: Implications to Antibody-Based Therapy.

Yair Gazitt, Ph.D, Cagla Akay, M.D, Deborah Doxey, Ph.D, Charles Thomas, Bs

Blood (2004) 104 (11): 4820.

https://doi.org/10.1182/blood.V104.11.4820.4820

Published: 2004

Journal Articles

Improved Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) and Dendritic Cells (DCs) by AMD-3100 (AMD) in Hard to Mobilize Non-Hodgkin’s Lymphoma (NHL) Patients (pts) Mobilized with Standard Dose of G-CSF.

Yair Gazitt, Ph.D, Cesar O Freytes, M.D, Cagla Akay, M.D, William Bensinger, M.D, Karin Badel, R.N, Gary Calandra, M.D

Blood (2004) 104 (11): 2856.

https://doi.org/10.1182/blood.V104.11.2856.2856

Published: 2004

Journal Articles

Comparison between G-CSF and GM-CSF for Mobilization of Dendritic Cells, CD34+ Cells, and CD3+ Cells in Normal Donors.

Paul J. Shaughnessy, MD, Carlos Bachier, MD, Al Nanez, BS, Cagla Akay, MD, C. F. LeMaistre, MD, Yair Gazitt, PhD

Blood (2004) 104 (11): 2870.

https://doi.org/10.1182/blood.V104.11.2870.2870

Published: 2004

Journal Articles

Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells: Presented in abstract form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001. 33

Qun Liu, Yair Gazitt

Blood (2003) 101 (10): 4105–4114.

https://doi.org/10.1182/blood-2002-10-3067

Published: 2003

Journal Articles

Arsenic trioxide–induced apoptosis in myeloma cells: p53-dependent G 1 or G 2 /M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL: Presented in preliminary form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 8, 2001. 42

Qun Liu, Susan Hilsenbeck, Yair Gazitt

Blood (2003) 101 (10): 4078–4087.

https://doi.org/10.1182/blood-2002-10-3231

Published: 2003

Journal Articles

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis

Jeanne E. Anderson, Ayalew Tefferi, Fiona Craig, Leona Holmberg, Thomas Chauncey, Frederick R. Appelbaum, Philippe Guardiola, Natalie Callander, Cesar Freytes, Yair Gazitt, Betty Razvillas, H. Joachim Deeg

Blood (2001) 98 (3): 586–593.

https://doi.org/10.1182/blood.V98.3.586

Published: 2001

NARROW

An In Vivo Mouse Model for Testing the Effect On Hematopoietic Stem Cell Mobilization of Bortezomib Alone and in Combination with G-CSF.

Not all that glitters is gold

Synergy between 17 AAG and Arsenic Trioxide in the Induction of Apoptosis in Myeloma Cell Lines.

Global Gene Expression Changes during Arsenic Trioxide -Induced Apoptosis in Myeloma Cell Lines Expressing Mutant or w.t p53.

Arsenic Trioxide Induced p53-Dependant Apoptotic Signals in a Temperature Sensitive (Ts) p53 Mutant, BRK Cell Line.

Synergy between CD52 and CD20 Antibody-Induced Apoptosis Correlates with the Extent of Co-Expression of CD20 and CD52 Antigens on Mononuclear Cells Derived from Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL) Patients: Implications to Antibody-Based Therapy.

Improved Mobilization of CD34+ Peripheral Blood Stem Cells (PBSC) and Dendritic Cells (DCs) by AMD-3100 (AMD) in Hard to Mobilize Non-Hodgkin’s Lymphoma (NHL) Patients (pts) Mobilized with Standard Dose of G-CSF.

Comparison between G-CSF and GM-CSF for Mobilization of Dendritic Cells, CD34+ Cells, and CD3+ Cells in Normal Donors.

Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells: Presented in abstract form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001. 33

Arsenic trioxide–induced apoptosis in myeloma cells: p53-dependent G 1 or G 2 /M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL: Presented in preliminary form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 8, 2001. 42

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only